首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   347639篇
  免费   23219篇
  国内免费   7642篇
耳鼻咽喉   4303篇
儿科学   9590篇
妇产科学   6632篇
基础医学   29771篇
口腔科学   8302篇
临床医学   38032篇
内科学   42688篇
皮肤病学   4798篇
神经病学   20268篇
特种医学   9318篇
外国民族医学   36篇
外科学   36843篇
综合类   51758篇
现状与发展   12篇
一般理论   30篇
预防医学   35283篇
眼科学   5550篇
药学   30174篇
  381篇
中国医学   30555篇
肿瘤学   14176篇
  2023年   5396篇
  2022年   8465篇
  2021年   13499篇
  2020年   12539篇
  2019年   18353篇
  2018年   16056篇
  2017年   12964篇
  2016年   10485篇
  2015年   9840篇
  2014年   20179篇
  2013年   21841篇
  2012年   18580篇
  2011年   20159篇
  2010年   16196篇
  2009年   14938篇
  2008年   14715篇
  2007年   15160篇
  2006年   13260篇
  2005年   11501篇
  2004年   9395篇
  2003年   8286篇
  2002年   6529篇
  2001年   5829篇
  2000年   4856篇
  1999年   4186篇
  1998年   3435篇
  1997年   3301篇
  1996年   2863篇
  1995年   2743篇
  1994年   2603篇
  1993年   2074篇
  1992年   2071篇
  1991年   1789篇
  1990年   1585篇
  1989年   1428篇
  1988年   1338篇
  1987年   1150篇
  1985年   3841篇
  1984年   4830篇
  1983年   3361篇
  1982年   3816篇
  1981年   3561篇
  1980年   3165篇
  1979年   2911篇
  1978年   2539篇
  1977年   1912篇
  1976年   2154篇
  1975年   1636篇
  1974年   1429篇
  1973年   1278篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
  1. Download : Download high-res image (232KB)
  2. Download : Download full-size image
  相似文献   
82.
83.
脑卒中患者在面对复杂的治疗期、漫长的康复期及难以预测的病情变化时容易产生对疾病或疾病进展的恐惧。恐惧疾病进展会损害脑卒中患者的身心健康和社会功能,最终影响患者的康复和预后。从恐惧疾病进展的定义、测量工具、国内外研究现状及影响因素几个方面进行综述,为临床护理人员深入了解脑卒中患者恐惧疾病进展现状、开展相关护理实践和临床研究提供依据。  相似文献   
84.
目的 探讨模拟诊疗在留学生心血管内科实习带教中的应用效果。方法 将35名留学生随机编号,分成试验组和对照组。试验组18名学生分成3组(每组6名)进行模拟诊疗教学,对照组17名学生进行常规实习。通过填写评价单和相关的临床能力测试对两组教学效果进行评价。选用SPSS 19.0软件进行t检验。结果 参与模拟诊疗教学的留学生均希望在各科实习中多采用此方法。在临床能力测试方面,试验组学生在病史采集[(22.16±2.17)vs.(20.33±2.03)]、体格检查[(23.05±1.79)vs.(19.78±2.05)]及回答问题[(23.50±1.47)vs.(19.56±1.92)]方面均优于对照组,差异有统计学意义(P<0.05)。但是在病历书写方面,两组差异无统计学意义(P>0.05)。结论 利用高仿真的模拟诊疗教学手段,弥补了留学生在实习期间不能充分接触患者的缺陷,有助于提高其临床操作技能、增强医患沟通能力等医学职业素养。  相似文献   
85.
This paper describes country-wide special measures undertaken for interventional radiology staff during the current coronavirus disease 2019 (COVID-19) pandemic. Although each interventional radiology service around the world faces unique challenges, the principles outlined in this article will be useful when designing or strengthening individual practices and integrating them within wider hospital and national measures. Moving beyond the current outbreak, these measures will be useful for any future infectious diseases which are likely to arise.  相似文献   
86.
87.

Background

Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.

Methods

Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.

Results

Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).

Conclusions

Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF.  相似文献   
88.
IntroductionPredicting pathological complete response (pCR) for patients receiving neoadjuvant chemotherapy (NAC) is crucial in establishing individualized treatment. Whole-slide images (WSIs) of tumor tissues reflect the histopathologic information of the tumor, which is important for therapeutic response effectiveness. In this study, we aimed to investigate whether predictive information for pCR could be detected from WSIs.Materials and methodsWe retrospectively collected data from four cohorts of 874 patients diagnosed with biopsy-proven breast cancer. A deep learning pathological model (DLPM) was constructed to predict pCR using biopsy WSIs in the primary cohort, and it was then validated in three external cohorts. The DLPM could generate a deep learning pathological score (DLPs) for each patient; stromal tumor-infiltrating lymphocytes (TILs) were selected for comparison with DLPs.ResultsThe WSI feature-based DLPM showed good predictive performance with the highest area under the curve (AUC) of 0.72 among the cohorts. Alternatively, the combination of the DLPM and clinical characteristics offered a better prediction performance (AUC >0.70) in all cohorts. We also evaluated the performance of DLPM in three different breast subtypes with the best prediction for the triple-negative breast cancer (TNBC) subtype (AUC: 0.73). Moreover, DLPM combined with clinical characteristics and stromal TILs achieved the highest AUC in the primary cohort (AUC: 0.82) and validation cohort 1 (AUC: 0.80).ConclusionOur study suggested that WSIs integrated with deep learning could potentially predict pCR to NAC in breast cancer. The predictive performance will be improved by combining clinical characteristics. DLPs from DLPM can provide more information compared to stromal TILs for pCR prediction.  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号